Dushay, Jody

Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease

Dushay, J., Chui, P. C., Gopalakrishnan, G. S., Varela–Rey, M., Crawley, M., Fisher, F. M., Badman, M. K., Martinez–Chantar, M. L., & Maratos–Flier, E. (2010) · Gastroenterology

Fibroblast Growth Factor ResearchLiver Disease Diagnosis and Treatment

Cited by 607

Fructose ingestion acutely stimulates circulating FGF21 levels in humans

Dushay, J. R., Toschi, E., Mitten, E. K., Fisher, F. M., Herman, M. A., & Maratos-Flier, E. (2015) · Molecular Metabolism

Fibroblast Growth Factor ResearchDiet, Metabolism, and Disease

Cited by 233

Integrating diet and physical activity when prescribing GLP-1s—Lifestyle factors remain crucial

Mehrtash, F., Dushay, J., & Manson, J. E. (2025) · JAMA Internal Medicine

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 44

Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women

Rodgers, M., Migdal, A. L., Rodríguez, T. G., Chen, Z.-Z., Nath, A. K., Gerszten, R. E., Kasid, N., Toschi, E., Tripaldi, J., Heineman, B., et al. (2021) · Frontiers in Endocrinology

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 24

I am taking a GLP-1 weight-loss medication—What should I know

Mehrtash, F., Dushay, J., & Manson, J. E. (2025) · JAMA Internal Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 19